We are currently testing whether simultaneous deletion of Klf5 and other genes that are frequently deleted in human prostate cancer, including PTEN at 10q23 and NKX3-1 at 8p21, could induce tumorigenesis. This evidence concerns the gene KLF5 and prostate cancer.